Detailed Information on Publication Record
2015
A recurrent deletion on chromosome 2q13 is associated with developmental delay and mild facial dysmorphisms
HLADÍLKOVÁ, Eva, Tuva BARØYA, Madeleine FANNEMELA, Vladimíra VALLOVÁ, Doriana MISCEO et. al.Basic information
Original name
A recurrent deletion on chromosome 2q13 is associated with developmental delay and mild facial dysmorphisms
Authors
HLADÍLKOVÁ, Eva (203 Czech Republic), Tuva BARØYA (578 Norway), Madeleine FANNEMELA (578 Norway), Vladimíra VALLOVÁ (703 Slovakia, belonging to the institution), Doriana MISCEO (578 Norway), Vesna BRYND (578 Norway), Iva SLÁMOVÁ (203 Czech Republic, belonging to the institution), Šárka PRÁŠILOVÁ (203 Czech Republic), Petr KUGLÍK (203 Czech Republic, guarantor, belonging to the institution) and Eirik FRENGEN (578 Norway)
Edition
MOLECULAR CYTOGENETICS, Londýn, BioMed Central, 2015, 1755-8166
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.506
RIV identification code
RIV/00216224:14310/15:00086994
Organization unit
Faculty of Science
UT WoS
000358831000001
Keywords in English
2q13 deletion; developmental delay; facial dysmorphism; aCGH; BCL2L11; FBLN7; TMEM87B
Změněno: 24/3/2016 09:45, Ing. Andrea Mikešková
Abstract
V originále
We report two unrelated patients with overlapping 2q13 deletions (patient 1 in chr2:111415137-113194067 bp and patient 2 in chr2:110980342-113007823 bp, hg 19). Patient 1 presents with developmental delay, microcephaly and mild dysmorphic facial features, and patient 2 with autism spectrum disorder, borderline cognitive abilities, deficits in attention and executive functions and mild dysmorphic facial features. The mother and maternal grandmother of patient 1 were healthy carriers of the deletion. Previously, 2q13 deletions were reported in 27 patients, and the interpretation of its clinical significance varied. Our findings support that the 2q13 deletion is associated with a developmental delay syndrome manifesting with variable expressivity and reduced penetrance which poses a challenge for genetic counselling as well as the clinical recognition of 2q13 deletion patients.
Links
EE2.3.20.0183, research and development project |
|